ArthroMeda

Arthromeda specializes in developing patient-specific solutions for arthroplasty surgery, focusing on improving the precision and fit of orthopedic implants. The company leverages proprietary technologies, including micro sensors, wireless systems, and custom software applications, to create innovative tools that enhance surgical outcomes. Arthromeda's primary product, ArthroSight PS Hip, is a real-time micro sensor intelligent platform designed for computer-assisted hip arthroplasty surgery. Additionally, the company is developing ArthroSight PS Knee, which will utilize similar technologies.

Arthromeda operates in the global joint replacement market, which is expected to reach $33 billion by 2022 due to the rising prevalence of joint replacement procedures. The company's business model revolves around providing cost-effective solutions that reduce the total cost of implant revisions caused by misalignment, which can add up to 300% in additional costs. By improving preoperative digital templating and alignment precision, Arthromeda aims to minimize the potential additional procedure time associated with existing navigation systems, which can be as high as 23 minutes.

Arthromeda serves orthopedic surgeons and healthcare providers looking for advanced, reliable, and cost-effective tools to enhance surgical precision and patient outcomes. The company generates revenue through the sale of its proprietary platforms and software solutions, which are designed to integrate seamlessly into existing surgical workflows.

Keywords: arthroplasty, orthopedic implants, micro sensors, wireless technologies, custom software, digital templating, surgical precision, cost-effective, patient-specific, healthcare innovation.